(b)(4).Our manufacturing process was within control and no abnormality was found on the given product lot.The product lot met all the qa outgoing inspection criteria prior releasing to the market.Based on the results of reserved samples evaluation and dhr analysis, there was no abnormality found on complaint lot.Investigation was carried out for reported lot 180830331.Based on the results of dhr analysis and reserve samples evaluation, there was no abnormality found on the reported product lot.We would like to emphasize that our manufacturing process was within control and all our products met the jms qa outgoing inspection criteria prior to market release.As per the information provided by facility and (b)(4), no defect or malfunction was observed of the jms sysloc mini avf.Hence, this incident is not related to our manufacturing process.Nonetheless, briefing was conducted on 26 dec 2018 to all related operators and inspectors for their awareness on the reported defect.(b)(4).
|
On (b)(6) 2018, a hemodialysis patient, arrived to treatment; pre-dialysis vs obtained b/p 153/77; pulse 86; resp 17; temp 97.8.Approximately 2 hours into the scheduled 4 hour hemodialysis treatment vs obtained were: b/p 97/52; pulse 84.The ultrafiltration was turned off and the patient's legs were elevated.The machine subsequently alarmed venous pressure and the blood pump stopped.The patient was lethargic and slow to respond verbally with the venous needle dislodged with the tape intact on the wings of the needle.Blood was noted to be flowing down the inside of the chair; a puddle of blood was under the chair.Estimated blood loss (ebl) was 1 unit.Approximately 400 mls normal saline was administered.Ems was called.Upon discharge from the facility via ems, patient was oriented with b/p 102/64; pulse 118.The patient was admitted to the hospital.1 unit of pack red blood cells (prbcs) was infused in the er.
|